Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...

Carterra Inc., the leading provider of technologies enabling high-throughput biology, today announced the launch of the ...

Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...

Partnership unites advanced screening solutions with world-class small molecule libraries. Peapod Bio Inc., a leader in innovative assay development and high-throughput screening (HTS) solutions, ...